Health In Tech, Inc.
NASDAQ:HITSoftware - Application
+$0.00 today
- Market cap
- $50.13M
- Beta
- 2.94
- P/E (TTM)
- -75.2
- EPS (TTM)
- -$0.01
Volume 0.04M
Average 0.23M
Returns on capital
Health In Tech, Inc. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
7.5%
avg 15.2%
ROIC
6.5%
avg 10.7%
ROA
5.5%
avg 7.9%
Analysis
ROE is currently the strongest return metric at 7.5% versus its period average of 15.2%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Tim Johnson | Founder, Chief Executive Officer & Chairman | USD 420K | 61 | — | — |
Jonathan Lockett | Chief Strategy Officer | USD 401K | 64 | — | — |
Julia Qian | Chief Financial Officer & Director | USD 360K | 50 | — | — |
Sri Rajagopalan | Chief Technology Officer | USD 251.3K | 57 | — | — |
Glenn Hillyer | Senior Vice President of Sales Partner Relations | — | 61 | — | — |
Michael Clarkson | Chief Information Security Officer | — | 51 | — | — |
John McStravock | General Counsel | — | — | 0 | <0.01% |
Zain Hasan | Chief Growth Officer | — | 38 | — | — |
Lori Babcock | Chief of Staff | — | 61 | — | — |
Compensation is shown in the reported currency; data updated Aug 29, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Apr 10, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
No open-market purchases or sales in the last 12 months.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +137.1% | +58.1% (2yr)2 analysts |
| Revenue | N/A | N/A | +79.4% | +46.2% (2yr)2 analysts |
| Net Income | N/A | N/A | +152.2% | N/A2 analysts |
| EBIT | N/A | N/A | +95.2% | N/A2 analysts |
Analysis
Recent growth has been strongest in Net Income at +152.2% over three years. Forward estimates point to EPS at +58.1% (2yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does Health In Tech, Inc. compete with?
Open similar companies to compare how their management teams allocate capital.
Questions
Management questions
Common questions about HIT's management, answered from reported figures.
Who manages HIT?
Health In Tech, Inc. (HIT) lists 9 active executives. The top listed executive is Tim Johnson, Founder, Chief Executive Officer & Chairman.
Are HIT insiders buying or selling?
Recent insider activity shows net buying of $71,334.07.
Continue the stock analysis
Jump to another research area for this company.